The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-09-22
Type
Journal Article
Author
Alexander E. Gorbalenya
Author
Susan C. Baker
Author
Ralph S. Baric
Author
Raoul J. de Groot
Author
Christian Drosten
Author
Anastasia A. Gulyaeva
Author
Bart L. Haagmans
Author
Chris Lauber
Author
Andrey M. Leontovich
Author
Benjamin W. Neuman
Author
Dmitry Penzar
Author
Stanley Perlman
Author
Leo L. M. Poon
Author
Dmitry V. Samborskiy
Author
Igor A. Sidorov
Author
Isabel Sola
Author
John Ziebuhr
Author
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
URL
https://www.nature.com/articles/s41564-020-0695-z
Rights
2020 The Author(s), under exclusive licence to Springer Nature Limited
Volume
5
Issue
4
Pages
536-544
Publication
Nature Microbiology
ISSN
2058-5276
Date
02/03/2020
Extra
Number: 4
Publisher: Nature Publishing Group
DOI
10.1038/s41564-020-0695-z
Library Catalog
www.nature.com
Language
en
Abstract
The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic. The Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the classification of viruses and taxon nomenclature of the family Coronaviridae, has assessed the placement of the human pathogen, tentatively named 2019-nCoV, within the Coronaviridae. Based on phylogeny, taxonomy and established practice, the CSG recognizes this virus as forming a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus, and designates it as SARS-CoV-2. In order to facilitate communication, the CSG proposes to use the following naming convention for individual isolates: SARS-CoV-2/host/location/isolate/date. While the full spectrum of clinical manifestations associated with SARS-CoV-2 infections in humans remains to be determined, the independent zoonotic transmission of SARS-CoV and SARS-CoV-2 highlights the need for studying viruses at the species level to complement research focused on individual pathogenic viruses of immediate significance. This will improve our understanding of virus–host interactions in an ever-changing environment and enhance our preparedness for future outbreaks.
Short Title
The species Severe acute respiratory syndrome-related coronavirus